Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Carbidopa in Familial Dysautonomia: Phase-II Study, Investigational New Drug (IND) 117435, Date: 01/07/13

NCT02553265 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT02553265
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02553265 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Carbidopa in Familial Dysautonomia: Phase-II Study, Investigational New Drug (IND) 117435, Date: 01/07/13
Lead sponsor
NYU Langone Health
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2015
Completion date
May 10, 2019
Enrollment
22 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

baroreflex failure syndrome, dysautonomia, familial